====== Citral 75μM R06 exp275 ======
==== Mechanism of Action ====
putative ALDH inhibitor, essential oil
* **Class / Subclass 1:** Uncharacterized Mechanism / Natural Product
* **Class / Subclass 2:** Metabolism / Metabolic Enzyme Inhibitor
==== Technical Notes ====
* **PubChem Name:** %%Citral%%
* **Synonyms:** N/A
* **CAS #:** 5392-40-5
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/638011|638011]]
* **IUPAC:** %%(2E)-3,7-dimethylocta-2,6-dienal%%
* **INCHI Name:** InChI=1S/C10H16O/c1-9(2)5-4-6-10(3)7-8-11/h5,7-8H,4,6H2,1-3H3/b10-7+
* **INCHI Key:** WTEVQBCEXWBHNA-JXMROGBWSA-N
* **Molecular Weight:** 152.23
* **Canonical SMILES:** CC(=CCCC(=CC=O)C)C
* **Isomeric SMILES:** CC(=CCC/C(=C/C=O)/C)C
* **Molecular Formula:** C10H16O
{{:chemogenomics:structures:chem-0166.svg?nolink}}
* **Supplier Name:** Sigma-Aldrich
* **Catalog #:** C83007
* **Lot #:** MKBL6233V
* **LCMS:** Tr 1.23 min, m/z 135+ [M+H-H2O]+.
* **Platform ID:** Citral
* **Min:** -22.4332; **Max:** 72.2322
{{:chemogenomics:dose_response:dr_283.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |N/A |
| IC30 |N/A |
| IC40 |N/A |
| IC50 |N/A |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 06
* **Dose**: 75µM
* **Days of incubation**: 8
* **Doublings**: 1.4
* **Numbers of reads**: 8529157
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|3/14|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Citral_75uM_Round-6_exp275.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp275.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:T:TCF4|TCF4]]|-3.32|<0.01|
|[[:human_genes:P:PRKAA1|PRKAA1]]|-3.02|<0.01|
|[[:human_genes:M:MTCH2|MTCH2]]|-2.84|0.05|
|[[:human_genes:A:ABCC1|ABCC1]]|-2.70|0.07|
|[[:human_genes:X:XPR1|XPR1]]|-2.47|0.08|
|[[:human_genes:R:RHOA|RHOA]]|-2.41|0.11|
|[[:human_genes:D:DPRX|DPRX]]|-2.39|0.11|
|[[:human_genes:C:CSK|CSK]]|-2.33|0.21|
|[[:human_genes:R:RAB24|RAB24]]|-2.25|0.21|
|[[:human_genes:T:TRIP12|TRIP12]]|-2.23|0.21|
|[[:human_genes:P:PRKAG1|PRKAG1]]|-2.23|0.37|
|[[:human_genes:G:GABARAP|GABARAP]]|-2.20|0.21|
|[[:human_genes:M:MEIG1|MEIG1]]|-2.13|0.49|
|[[:human_genes:A:ANAPC15|ANAPC15]]|-2.09|0.37|
|[[:human_genes:C:CYLD|CYLD]]|-2.08|0.37|
|[[:human_genes:T:TRIM44|TRIM44]]|-2.07|0.37|
|[[:human_genes:N:NPRL3|NPRL3]]|-2.07|0.48|
|[[:human_genes:C:C11orf30|C11orf30]]|-2.06|0.37|
|[[:human_genes:H:HIST1H3E|HIST1H3E]]|-2.06|0.37|
|[[:human_genes:T:TBC1D17|TBC1D17]]|-2.04|0.37|
|[[:human_genes:G:GPR21|GPR21]]|-2.03|0.37|
|[[:human_genes:C:CFLAR|CFLAR]]|-2.03|0.37|
|[[:human_genes:G:GPBP1|GPBP1]]|-2.02|0.37|
|[[:human_genes:S:SLC9A8|SLC9A8]]|-2.02|0.37|
|[[:human_genes:F:FBXL5|FBXL5]]|-1.98|0.37|
|[[:human_genes:G:GIGYF2|GIGYF2]]|-1.96|0.48|
|[[:human_genes:S:SLC16A5|SLC16A5]]|-1.96|0.37|
|[[:human_genes:M:MORF4L1|MORF4L1]]|-1.95|0.37|
|[[:human_genes:S:SEPHS2|SEPHS2]]|-1.95|0.37|
|[[:human_genes:C:CXCR4|CXCR4]]|-1.95|0.37|
|[[:human_genes:R:RICTOR|RICTOR]]|2.24|0.08|
|[[:human_genes:A:ALAD|ALAD]]|2.24|0.15|
|[[:human_genes:S:SLC7A1|SLC7A1]]|2.24|0.26|
|[[:human_genes:Z:ZBTB18|ZBTB18]]|2.25|0.08|
|[[:human_genes:E:EIF3B|EIF3B]]|2.26|0.34|
|[[:human_genes:F:FGFR4|FGFR4]]|2.27|0.07|
|[[:human_genes:S:SIX2|SIX2]]|2.28|0.12|
|[[:human_genes:D:DPH5|DPH5]]|2.31|0.06|
|[[:human_genes:E:EIF3A|EIF3A]]|2.37|0.05|
|[[:human_genes:T:TRMT61A|TRMT61A]]|2.39|0.21|
|[[:human_genes:P:PDS5B|PDS5B]]|2.42|0.04|
|[[:human_genes:D:DRG1|DRG1]]|2.46|0.06|
|[[:human_genes:M:METTL1|METTL1]]|2.49|0.05|
|[[:human_genes:A:AP1M1|AP1M1]]|2.49|0.03|
|[[:human_genes:D:DAO|DAO]]|2.51|0.05|
|[[:human_genes:M:METTL21D|METTL21D]]|2.55|0.03|
|[[:human_genes:A:ATP5B|ATP5B]]|2.58|0.04|
|[[:human_genes:N:NHP2L1|NHP2L1]]|2.65|0.18|
|[[:human_genes:H:HSD17B12|HSD17B12]]|2.69|0.05|
|[[:human_genes:P:PIK3CD|PIK3CD]]|2.71|0.02|
|[[:human_genes:C:CD19|CD19]]|2.75|0.02|
|[[:human_genes:D:DPH2|DPH2]]|2.76|0.02|
|[[:human_genes:A:ACSL3|ACSL3]]|2.83|0.02|
|[[:human_genes:M:MIDN|MIDN]]|2.85|<0.01|
|[[:human_genes:H:HMHA1|HMHA1]]|2.96|0.02|
|[[:human_genes:A:ATPAF2|ATPAF2]]|3.18|<0.01|
|[[:human_genes:R:RBM26|RBM26]]|3.22|<0.01|
|[[:human_genes:L:LRRC63|LRRC63]]|3.37|0.18|
|[[:human_genes:A:ATP5A1|ATP5A1]]|3.69|<0.01|
|[[:human_genes:P:PRRC2C|PRRC2C]]|3.87|<0.01|
^Screen^Correlation^Plot^
|[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|0.076||
|[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|0.069||
|[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|0.061||
|[[:results:exp439|QNZ 0.01μM R08 exp439]]|0.058||
|[[:results:exp234|Ethanol 0.01 R05 exp234]]|0.054||
|[[:results:exp431|Rotenone 0.07μM R08 exp431]]|0.053||
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|0.053||
|[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|0.053||
|[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|0.052||
|[[:results:exp274|Citral 50μM R06 exp274]]|0.078||
|[[:results:exp466|Cannabidiol 20μM R08 exp466]]|0.07||
|[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|0.069||
|[[:results:exp447|Amiloride 100μM R08 exp447]]|0.053||
|[[:results:exp269|Bisphenol A 100μM R06 exp269]]|0.051||
{{:chemogenomics:comparison_plots:exp275_vs_exp488.png?nolink |}}
{{:chemogenomics:comparison_plots:exp275_vs_exp489.png?nolink |}}
{{:chemogenomics:comparison_plots:exp275_vs_exp535.png?nolink |}}
{{:chemogenomics:comparison_plots:exp275_vs_exp439.png?nolink |}}
{{:chemogenomics:comparison_plots:exp234_vs_exp275.png?nolink |}}
{{:chemogenomics:comparison_plots:exp275_vs_exp431.png?nolink |}}
{{:chemogenomics:comparison_plots:exp275_vs_exp445.png?nolink |}}
{{:chemogenomics:comparison_plots:exp102_vs_exp275.png?nolink |}}
{{:chemogenomics:comparison_plots:exp275_vs_exp526.png?nolink |}}
{{:chemogenomics:comparison_plots:exp274_vs_exp275.png?nolink |}}
{{:chemogenomics:comparison_plots:exp275_vs_exp466.png?nolink |}}
{{:chemogenomics:comparison_plots:exp275_vs_exp334.png?nolink |}}
{{:chemogenomics:comparison_plots:exp275_vs_exp447.png?nolink |}}
{{:chemogenomics:comparison_plots:exp269_vs_exp275.png?nolink |}}
^GO Term^Fold Change^Genes^
|proline-rich region binding|119.51|CSK,CYLD,GIGYF2|
^GO Term^Fold Change^Genes^
|angiostatin binding|368.27|ATP5F1A,ATP5F1B|
|proton-transporting ATP synthase complex, catalytic core F(1)|331.44|ATP5F1A,ATP5F1B,ATP5PO|
|mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1)|276.20|ATP5F1A,ATP5F1B|
|proton-transporting ATP synthase activity, rotational mechanism|118.37|ATP5F1A,ATP5F1B,ATP5PO|
|mitochondrial proton-transporting ATP synthase complex|110.48|ATP5F1A,ATP5F1B,ATP5PO|
|proton-transporting two-sector ATPase complex, catalytic domain|97.48|ATP5F1A,ATP5F1B,ATP5PO|
|purine ribonucleotide biosynthetic process|15.78|ATP5F1A,ACSL3,HSD17B12,ATP5F1B,ATP5PO|